Company facts
- Headquarters
- Dallas, Texas
- Most recent report
- 10-Q, filed Aug 11, 2026
- Incorporated
- Delaware
- Filings on record
- 401 filings
- On EDGAR
- CIK 1806310
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 25
News 8 of 90
Prospectuses and Registrations 8 of 30
- 424B5 Prospectus supplement for an offering Jun 25, 2026
- 424B5 Prospectus supplement for an offering Jun 24, 2026
- S-8 Registration statement for an employee plan Jan 6, 2026
- S-3ASR Automatic shelf registration Nov 4, 2025
- 424B5 Prospectus supplement for an offering May 29, 2025
- 424B5 Prospectus supplement for an offering May 28, 2025
- S-8 Registration statement for an employee plan Jan 7, 2025
- S-3 Shelf registration statement Dec 13, 2024
Proxies 8 of 16
- DEFA14A Extra proxy material Apr 22, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 22, 2026
- DEFR14A May 9, 2025
- DEFA14A Extra proxy material Apr 21, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 21, 2025
- PRE 14A Preliminary proxy statement Apr 10, 2025
- DEFA14A Extra proxy material Apr 18, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 18, 2024
Ownership 8 of 206
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 13, 2026
- 4 Insider reported a trade Jul 10, 2026
- 144 Notice of a proposed sale of restricted stock Jul 10, 2026
- 4 Insider reported a trade Jun 2, 2026
- 4 Insider reported a trade Jun 2, 2026
- 4 Insider reported a trade Jun 2, 2026
- 4 Insider reported a trade Jun 2, 2026
Other 8 of 34
- ARS Annual report sent to shareholders Apr 22, 2026
- ARS Annual report sent to shareholders Apr 21, 2025
- EFFECT Notice that a registration became effective Dec 20, 2024
- CORRESP Reply to SEC staff Dec 20, 2024
- CORRESP Reply to SEC staff Dec 19, 2024
- UPLOAD Comment letter from SEC staff Dec 18, 2024
- ARS Annual report sent to shareholders Apr 18, 2024
- EFFECT Notice that a registration became effective Sep 8, 2023
Everything here comes from Taysha Gene Therapies, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.